Lee Victoria Tou-ho 4

What Happened

• Lee Victoria Tou-ho, Chief Medical Officer of PAVmed Inc. (PAVM), was granted 70,000 restricted shares on April 2, 2026. The Form 4 reports the acquisition as an award/grant (transaction code A) with an acquisition price of $0.00 (total reported value $0).
• This was a compensation grant (not a market buy or sell). The shares are restricted and subject to a single vesting date.

Key Details

• Transaction date: 2026-04-02; Form 4 filed: 2026-04-13 (filed late — beyond the typical two-business-day deadline).
• Reported acquisition: 70,000 shares at $0.00 per share (transaction code A).
• Shares owned after transaction: not specified in the filing.
• Footnote: Grant is restricted stock under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan, with a single vesting date of May 20, 2029; shares are forfeitable if requisite service is not completed.

Context

• Restricted stock awards are a common form of executive compensation and do not represent an immediate market purchase or sale. They generally align executive incentives with shareholder value over the vesting period.
• The late filing delays public disclosure of the grant; late Form 4s can reduce the timeliness of information available to investors but do not, by themselves, indicate misconduct.